Six protocols. One coherent method.
Every protocol here is an educational reference. Individualized recommendations require review by a licensed clinician under applicable state law.
Supervised Rosuvastatin Rechallenge
A cautious, stepwise rosuvastatin rechallenge for adults with elevated cholesterol and reported difficulty tolerating prior statin therapy, coordinated with cardiology and lifestyle optimization.
Lipid Therapy in Decompensated Cirrhosis
Careful lipid-lowering strategy for patients with decompensated hepatic cirrhosis, elevated liver biochemistries, and documented MELD and Child-Pugh scores, coordinated with hepatology.
Familial Hypercholesterolemia (FH)
High-intensity lipid-lowering strategy for suspected or confirmed familial hypercholesterolemia, with genetics referral, cascade evaluation, and early advanced-therapy authorization.
Hypertriglyceridemia
Nutrition-first management for mildly elevated triglycerides, with stepwise consideration of omega-3s and prescription therapy for higher elevations.
LDL Cholesterol Goals — Extended Reference
A consolidated reference summarizing LDL cholesterol targets across primary prevention, secondary prevention, familial hypercholesterolemia, and elevated Lp(a), aligned with contemporary preventive cardiology guidance.
Isolated Elevated Lp(a)
An elevated lipoprotein(a) concentration is a genetically determined cardiovascular risk enhancer and should be incorporated into overall ASCVD risk assessment, even when the routine lipid profile is otherwise favorable.